Satellos Bioscience Inc. (MSLE)

NASDAQ: MSLE · Real-Time Price · USD

6.63

-0.21 (-3.00%)

At close: Nov 13, 2026, 4:00 PM EST

6.70

+0.08 (1.13%)

After-hours: Nov 13, 2026, 7:30 PM EST

Satellos Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.18	9.8	40.07	16.71	1.42	3.85
Short-Term Investments	46.84	17.91	8.48	13.27	-	-
Cash & Short-Term Investments	53.01	27.71	48.55	29.98	1.42	3.85
Cash Growth	53.16%	-42.92%	61.96%	2008.62%	-63.07%	583.57%
Other Receivables	0.92	0.37	0.44	0.44	0.19	0.42
Receivables	0.92	0.37	0.44	0.44	0.19	0.42
Prepaid Expenses	4.04	0.19	0.18	0.11	0.03	0.03
Other Current Assets	-	3.62	1.58	0	0	-
Total Current Assets	57.98	31.88	50.74	30.53	1.65	4.3
Property, Plant & Equipment	0.01	0.01	0	0.01	0.01	0.01
Long-Term Investments	-	-	-	0.03	0.03	-
Other Intangible Assets	-	-	-	2.97	2.89	5.64
Total Assets	57.99	31.89	50.75	33.54	4.58	9.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.75	1.77	2.06	0.79	1.08	0.89
Accrued Expenses	-	-	-	1.96	1.01	0.77
Current Income Taxes Payable	-	0.07	-	-	-	-
Other Current Liabilities	-	2.26	1.52	-	-	-
Total Current Liabilities	8.36	4.11	3.58	2.74	2.09	1.66
Total Liabilities	8.36	4.11	3.58	2.74	2.09	1.66

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	135.44	85.83	78.13	46.88	22.32	22.38
Additional Paid-In Capital	12.66	10.17	7.9	6.44	2.72	0.98
Retained Earnings	-114.62	-81.97	-57.1	-35.97	-23.36	-16.03
Comprehensive Income & Other	16.14	13.76	18.23	13.45	0.8	0.97
Shareholders' Equity	49.62	27.78	47.16	30.8	2.49	8.28
Total Liabilities & Equity	57.99	31.89	50.75	33.54	4.58	9.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	53.01	27.71	48.55	29.98	1.42	3.85
Net Cash Growth	53.16%	-42.92%	61.96%	2008.62%	-63.07%	-
Net Cash Per Share	2.79	1.90	5.08	4.16	0.48	1.92
Filing Date Shares Outstanding	21.18	20.83	13.82	9.4	3.48	2.75
Total Common Shares Outstanding	21.18	15.46	13.82	9.4	3.48	2.75
Working Capital	49.62	27.78	47.16	27.79	-0.44	2.64
Book Value Per Share	2.34	1.80	3.41	3.28	0.71	3.01
Tangible Book Value	49.62	27.78	47.16	27.83	-0.4	2.64
Tangible Book Value Per Share	2.34	1.80	3.41	2.96	-0.12	0.96
Machinery	-	-	-	-	0.01	0.01

SEC Filings: 10-K · 10-Q